Mission Bio, Inc. has been awarded a firm fixed price purchase order valued at one hundred sixty-six thousand seven hundred twenty-nine dollars by the National Heart, Lung and Blood Institute (NHLBI) of the National Institutes of Health (NIH). The contract is for a project titled "Clonal Evolution of Driver Mutations" to be performed in South San Francisco, California over a one year period concluding in August 2024. As part of the NIH's efforts to advance understanding of the...
This firm-fixed-price purchase order was awarded by the National Institutes of Health (NIH) to Mission Bio, Inc., a for-profit manufacturer of biological supplies, reagent kits, sequencing instruments, and sequencing services. The $21,230 contract supports NIH's biomedical research and genomics efforts in areas such as infectious disease, hematology, oncology, and personalized medicine. Mission Bio has also received a $1.8 million National Cancer Institute grant to support measurable residual...
The U.S. National Institutes of Health (NIH) awarded a $21,230.00 firm fixed price purchase order to Mission Bio, Inc., a for-profit manufacturer of biological supplies and sequencing services. The contract is for Mission Bio's Tapestri Single Cell DNA and Protein Kit, which supports NIH's biomedical research and genomics efforts in areas like infectious disease, hematology, oncology, and personalized medicine. Mission Bio is a registered federal contractor that has previously received NIH...
The National Heart Lung and Blood Institute (NHLBI), a civilian agency within the National Institutes of Health (NIH), awarded a $34,966 firm fixed-price purchase order to Mission Bio, Inc., a for-profit manufacturer of biological supplies and sequencing services. The contract is for the delivery of Tapestri Single-Cell DNA + Protein Reagent Kits to support NHLBI's biomedical research and genomics efforts. The contract has a performance period through December 19, 2025 and does not utilize any...
Mission Bio, Inc. was awarded a $39,880 purchase order by the National Heart, Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to deliver single-cell DNA protein reagent kits. The firm-fixed price order is for a one-year base period of performance beginning September 15, 2023 through September 14, 2024 in South San Francisco, California. The original solicitation sought single-cell DNA and protein reagent kits to support NHLBI's research efforts...
The Department of Health and Human Services National Institutes of Health (NIH) Clinical Center awarded a firm-fixed-price purchase order contract to Mission Bio, Inc., a for-profit manufacturer, to provide a Tapestri Single-Cell DNA Training Kit. The contract has a potential value of $162,150.00 and a completion date of January 19, 2024. This award does not have a small business set-aside designation. Mission Bio is a vendor that has previously received prime federal contract awards and...
Mission Bio, Inc. was awarded an $11,130 firm fixed price purchase order by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to deliver a Mission Bio Tapestry single-cell DNA 4 sample proof of principle kit (version 3). The purchase order has a period of performance of just under one year, running from September 2023 through September 2024. Place of performance will be Mission Bio's facilities in South San Francisco, California. No subcontractors or set...
The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $134,160 purchase order to Mission Bio, Inc. of South San Francisco, California. The firm fixed price order is for Mission Bio Tapestri reagents and services to support the agency's biomedical research efforts. No major subcontractors or set aside designations were indicated. Mission Bio will provide its Tapestri single-cell DNA and RNA sequencing platform reagents from June 2023 through August...
The federal contract award is a firm fixed-price purchase order valued at $138,625 issued by the National Institutes of Health National Institute on Aging to Mission Bio, Inc. for the delivery of a Tapestri Multiome Sequencing Instrument. The instrument will support the agency's research efforts to sequence multiple types of biological data from a single sample. The contract has a period of performance from June 20th, 2023 through September 20th, 2023 with delivery to occur within 30 days of...
This is a $95,931.00 firm fixed price purchase order contract awarded by the National Heart Lung and Blood Institute (NHLBI), which is part of the National Institutes of Health (NIH), a civilian agency. The contract is for the purchase of an Illumina MiSeq2 sequencing system and associated components. Illumina, Inc., a for-profit manufacturer of genomic analysis instruments and reagents, is the prime contractor. This contract does not have a set-aside designation. Illumina has provided...